InogenStock Price and Value Analysis

Should you buy Inogen stock? (NasdaqGS:INGN). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

INGN Free Cash Flow Trend

Hmm, we can't give any reliable projection for Inogen's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for INGN
Free Cash Flow trendline for Inogen

Inside the INGN Numbers

INGN Price
(Inogen stock price per share)
$119.49
[?] PE Ratio versus Sector 379% higher than other Healthcare stocks
[?] PE Ratio versus Industry 302% higher than other Medical Instruments & Supplies stocks
[?] Cash Yield 2.09%
[?] Free Cash Flow Jitter 3403%

Is Inogen Stock on Sale?

Based on our analysis, we believe that you should not buy Inogen right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy INGN Stock?

Does Inogen have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.